-+ 0.00%
-+ 0.00%
-+ 0.00%

Alpha Cognition elects Robert Wills as board chairman

PUBT·06/23/2026 12:30:56
Listen to the news
Alpha Cognition elects Robert Wills as board chairman
  • Alpha Cognition elected Robert Wills as chairman, replacing Len Mertz, who retired from the board.
  • Wills has served on the board since 2025, chairs the governance and nominating committee, sits on the audit committee.
  • He is chairman at Milestone Pharmaceuticals, previously chaired CymaBay Therapeutics before its March 2024 sale to Gilead Sciences.
  • Wills spent more than 25 years at Johnson & Johnson, including senior roles in alliance management at Janssen and global development.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alpha Cognition Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202606230830BIZWIRE_USPR_____20260623_BW450250) on June 23, 2026, and is solely responsible for the information contained therein.